Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Clinical trial NCT02495103 · TERMINATED
Trial details
- NCT number
- NCT02495103
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-26
- Primary completion
- 2020-02-06
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.